IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BML Capital Management, LLC

Q3 2025 Holdings

Filed 2025-11-10 | 20 holdings | $109.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$27.1M14,250,00024.8%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$21.7M7,473,96319.8%
Adverum Biotechnologies Inc(AVU0)COM NEW00773U207$13.9M3,057,52612.7%
Instil BIO Inc(TIL)COM NEW45783C200$11.5M645,60010.6%
Oramed Pharmaceuticals Inc(ORMP)COM NEW68403P203$8.4M3,167,2317.7%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$7.4M5,292,0006.8%
Alumis Inc(ALMS)COM022307102$4.8M1,210,4154.4%
Lava Therapeutics NVSHSN51517105$3.1M1,970,6102.8%
Kezar Life Sciences Inc(KZR)COM NEW49372L209$2.8M720,7872.6%
Connect Biopharma Hldgs LTD(CNTB)SHSG23549101$1.9M1,267,5001.8%
Imagenebio Inc(IMA)COM45175G207$1.5M182,5091.4%
Athira Pharma Inc(LONA)COM04746L203$1.3M323,0661.2%
Astrotech Corp(ASTC)COM046484309$1.1M220,4101.0%
Target Corp(TGT)COM87612E106$897.0K10,0000.8%
Vistagen Therapeutics Inc(VTGN)COM92840H400$532.5K150,0000.5%
Walmart Inc(WMT)PutCOM931142103$518.7K2650.5%
Arvinas Inc(ARVN)COM04335A105$426.0K50,0000.4%
Lisata Therapeutics Inc(LSTA)COM128058302$287.8K109,8410.3%
Mural Oncology PUB LTD CoORD SHSG63365103$119.0K57,5000.1%
Third Harmonic BIO Inc(THRD)COM88427A107$03,824,4170.0%